Supriya Lifescience Quarterly Results for Trading Insights

SUPRIYA • Latest quarterly financial performance to support trade journaling in Tickjournal
Latest Quarter Net Profit
₹188 Cr
QMarch 2025
Quarterly Results

Supriya Lifescience Quarterly Results Key Highlights

  • Revenue of ₹706 Cr in March 2025 (+0.0% vs March 2025, +21.5% vs March 2024)
  • Net Profit of ₹188 Cr in March 2025 (+0.0% vs March 2025, +58.0% vs March 2024)
  • EBITDA of ₹271 Cr in March 2025 (+0.0% vs March 2025)
  • Operating Margin of 37.0% in March 2025 (+0.0pp vs March 2025)
  • Earnings Per Share of ₹23.35 in March 2025 (+0.0% vs March 2025)

Supriya Lifescience Quarterly Results Analysis

Metric 2026 March 2025 March 2024 March 2023 March 2022 QoQ YoY
Revenue (₹ Cr) 725 706 581 470 538 2.7% -
Net Profit (₹ Cr) 182 188 119 90 152 - -
EBITDA (₹ Cr) 269 271 184 138 222 - -
EPS (₹) 22.70 23.35 14.80 11.16 18.86 - -
Operating Margin (%) 36.0% 37.0% 30.0% 28.0% 40.0% - -

Supriya Lifescience Share Price Trend Around Quarterly Results

Visualize Supriya Lifescience's 1-year price movement across quarterly results — ideal for logging trades in Supriya Lifescience share price chart using Tickjournal. All values in ₹.

Related Pages for Supriya Lifescience

Additional stock information and data for SUPRIYA

SUPRIYA true value
SUPRIYA shareholding pattern
Supriya Lifescience price earnings
SUPRIYA stock valuation models
SUPRIYA market capitalization
Supriya Lifescience dividend payments
SUPRIYA cash flow statement
Supriya Lifescience 52-week

Profitability Ratios

Profit Margin 26.6%
EBITDA Margin 38.4%
Operating Margin 37.0%
ROE (Annual) 18.9%

Balance Sheet Highlights

Total Assets ₹1,112 Cr
Total Equity ₹997 Cr
Current Assets ₹437 Cr
Current Liabilities ₹33 Cr

Cash Flow Analysis

Operating Cash Flow ₹165 Cr
Investing Cash Flow ₹-152 Cr
Financing Cash Flow ₹-8 Cr
Net Cash Flow ₹4 Cr

Current Market Data

Current Price ₹758.75
Exchange NSE
Last Updated Jan 07, 2026

Revenue Trend (₹ Cr)

March 2023 470
March 2024 581
March 2025 706
2026 725

Net Profit Trend (₹ Cr)

March 2023 90
March 2024 119
March 2025 188
2026 182

Operating Margin Trend (%)

March 2023 28.0%
March 2024 30.0%
March 2025 37.0%
2026 36.0%

Sector Competitors - Quarterly Performance Comparison

Comparing Supriya Lifescience quarterly results with other companies in Healthcare sector
Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Sept 2025 		₹422,330.94 Cr 1782.6 14,875 3,125 +10.8% - 21.0% 137.1
Divis Laboratories
Sept 2025 		₹176,337.50 Cr 6642.5 2,860 689 +7.1% - 24.1% 255.8
Torrent Pharmaceuti…
Sept 2025 		₹136,522.12 Cr 4092.2 3,219 591 +11.3% - 18.4% 233.3
Cipla
Sept 2025 		₹121,238.47 Cr 1467.9 7,716 1,353 +12.0% - 17.5% 87.7
Dr Reddys Laborator…
Sept 2025 		₹104,829.57 Cr 1242.8 9,135 1,337 +1.1% - 14.6% 76.8
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data
QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores